Exclusive

Publication

Byline

Location

US Patent Issued to Flow Pharma on Sept. 8 for "Controlled release of antibodies to modulate cytokines" (California Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,237, issued on Sept. 8, was assigned to Flow Pharma Inc. (Redwood City, Calif.). "Controlled release of antibodies to modulate cytokines" w... Read More


US Patent Issued to MERCK PATENT on Sept. 8 for "Anti-CEACAM5 antibodies and conjugates and uses thereof" (German, Israeli Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,239, issued on Sept. 8, was assigned to MERCK PATENT GMBH (Darmstadt, Germany). "Anti-CEACAM5 antibodies and conjugates and uses thereof" w... Read More


US Patent Issued to ImmunEdge, The Board of Trustees of the Leland Stanford Junior University on Sept. 8 for "Method of increasing an immune response to a cancer by administering an antibody which inhibits erythropoietin receptor activation" (California Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,240, issued on Sept. 8, was assigned to ImmunEdge Inc. (Redwood City, Calif.) and The Board of Trustees of the Leland Stanford Junior Univer... Read More


US Patent Issued to Gilead Sciences on Sept. 8 for "Antibodies that bind to human chemokine (C-C motif) receptor 8 (CCR8)" (Massachusetts, California Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,241, issued on Sept. 8, was assigned to Gilead Sciences Inc. (Foster City, Calif.). "Antibodies that bind to human chemokine (C-C motif) re... Read More


US Patent Issued to Hoffmann-La Roche on Sept. 8 for "Dosing for treatment with anti-CD20/anti-CD3 bispecific antibody" (Swiss, British, American, French, German Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,243, issued on Sept. 8, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.). "Dosing for treatment with anti-CD20/anti-CD3 bispecif... Read More


US Patent Issued to The Board of Trustees of the Leland Stanford Junior University on Sept. 8 for "Compositions and methods for inhibiting T cell exhaustion" (California Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,245, issued on Sept. 8, was assigned to The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.). "Compositions an... Read More


US Patent Issued to Memorial Sloan Kettering Cancer Center on Sept. 8 for "Anti-GPA33 multi-specific antibodies and uses thereof" (New York Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,246, issued on Sept. 8, was assigned to Memorial Sloan Kettering Cancer Center (New York). "Anti-GPA33 multi-specific antibodies and uses t... Read More


US Patent Issued to Tate & Lyle Solutions USA on Sept. 8 for "Inhibited porous granular starches and methods of making and using them" (Illinois Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,247, issued on Sept. 8, was assigned to Tate & Lyle Solutions USA LLC (Hoffman Estates, Ill.). "Inhibited porous granular starches and meth... Read More


US Patent Issued to Roquette Freres on Sept. 8 for "Thermally modified starches" (French Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,248, issued on Sept. 8, was assigned to Roquette Freres (Lestrem, France). "Thermally modified starches" was invented by Solene Bock (Lambe... Read More


US Patent Issued to SHAANXI UNIVERSITY OF SCIENCE AND TECHNOLOGY on Sept. 8 for "Ganoderma lucidum beta-glucan extract, preparation method and detection method therefor" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,249, issued on Sept. 8, was assigned to SHAANXI UNIVERSITY OF SCIENCE AND TECHNOLOGY (Xi'an, China). "Ganoderma lucidum beta-glucan extract... Read More